Literature DB >> 17920402

Substandard application of preimplantation genetic screening may interfere with its clinical success.

Santiago Munné1, Luca Gianaroli, Ilan Tur-Kaspa, Cristina Magli, Mireia Sandalinas, Jamie Grifo, David Cram, Semra Kahraman, Yury Verlinsky, Joe L Simpson.   

Abstract

The intent of this study was to evaluate a recent randomized clinical trial evaluating the effect of preimplantation genetic screening (PGS) that reports a negative effect on pregnancy outcome. This article reviews appropriate PGS techniques and how they differ from the trial in question. A closer look at the clinical trial in question reveals significant lack of expertise in biopsy, cell fixation, genetic analysis, and patient selection. At most, this trial demonstrates that in inexperienced hands, PGS can be detrimental. No other conclusions concerning the effect of PGS on pregnancy results can be drawn from the trial.

Entities:  

Mesh:

Year:  2007        PMID: 17920402     DOI: 10.1016/j.fertnstert.2007.08.002

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  10 in total

1.  Use of parthenogenetic activation of human oocytes as an experimental model for evaluation of polar body based PGD assay performance.

Authors:  Alessio Paffoni; Valentina Paracchini; Stefania Ferrari; Claudia Scarduelli; Manuela Seia; Domenico A Coviello; Guido Ragni
Journal:  J Assist Reprod Genet       Date:  2011-03-01       Impact factor: 3.412

Review 2.  PGS-FISH in reproductive medicine and perspective directions for improvement: a systematic review.

Authors:  Sandra Zamora; Ana Clavero; M Carmen Gonzalvo; Juan de Dios Luna Del Castillo; Jose Antonio Roldán-Nofuentes; Juan Mozas; Jose Antonio Castilla
Journal:  J Assist Reprod Genet       Date:  2011-06-29       Impact factor: 3.412

Review 3.  Preimplantation genetic diagnosis for inherited neurological disorders.

Authors:  Ilan Tur-Kaspa; Roohi Jeelani; P Murali Doraiswamy
Journal:  Nat Rev Neurol       Date:  2014-05-27       Impact factor: 42.937

4.  Quantitative decision-making in preimplantation genetic (aneuploidy) screening (PGS).

Authors:  Michael C Summers; Andrew D Foland
Journal:  J Assist Reprod Genet       Date:  2009-10-22       Impact factor: 3.412

5.  Embryonic Cell-free DNA in Spent Culture Medium: A Non-invasive Tool for Aneuploidy Screening of the Corresponding Embryos.

Authors:  Afrodite Sialakouma; Ioannis Karakasiliotis; Vaia Ntala; Nikolaos Nikolettos; Byron Asimakopoulos
Journal:  In Vivo       Date:  2021 Nov-Dec       Impact factor: 2.155

6.  The Effect of Preimplantation Genetic Screening on Implantation Rate in Women over 35 Years of Age.

Authors:  Mina Moayeri; Hojatolah Saeidi; Mohammad Hossein Modarresi; Mehrdad Hashemi
Journal:  Cell J       Date:  2016-04-04       Impact factor: 2.479

7.  Extracellular embryo genomic DNA and its potential for genotyping applications.

Authors:  Luca Galluzzi; Simone Palini; Silvia De Stefani; Francesca Andreoni; Mariangela Primiterra; Aurora Diotallevi; Carlo Bulletti; Mauro Magnani
Journal:  Future Sci OA       Date:  2015-11-01

Review 8.  Postponing Pregnancy Through Oocyte Cryopreservation for Social Reasons: Considerations Regarding Clinical Practice and the Socio-Psychological and Bioethical Issues Involved.

Authors:  Mara Simopoulou; Konstantinos Sfakianoudis; Panagiotis Bakas; Polina Giannelou; Christina Papapetrou; Theodoros Kalampokas; Anna Rapani; Ekaterini Chatzaki; Maria Lambropoulou; Chrysoula Lourida; Efthymios Deligeoroglou; Konstantinos Pantos; Michael Koutsilieris
Journal:  Medicina (Kaunas)       Date:  2018-10-25       Impact factor: 2.430

9.  Use of comprehensive chromosomal screening for embryo assessment: microarrays and CGH.

Authors:  Dagan Wells; Samer Alfarawati; Elpida Fragouli
Journal:  Mol Hum Reprod       Date:  2008-10-28       Impact factor: 4.025

Review 10.  Preimplantation Genetic Diagnosis: Prenatal Testing for Embryos Finally Achieving Its Potential.

Authors:  Harvey J Stern
Journal:  J Clin Med       Date:  2014-03-17       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.